STRATA Skin Sciences (SSKN) Capital Expenditures (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,525.00% |
| Sep 30, 2025 | 34.43% |
| Jun 30, 2025 | -130.65% |
| Mar 31, 2025 | -87.84% |
| Dec 31, 2024 | 252.90% |
| Sep 30, 2024 | -410.14% |
| Jun 30, 2024 | -52.41% |
| Mar 31, 2024 | -57.80% |
| Dec 31, 2023 | 985.57% |
| Sep 30, 2023 | -111.39% |
| Jun 30, 2023 | -4.97% |
| Mar 31, 2023 | 5.47% |
| Dec 31, 2022 | 222.39% |
| Sep 30, 2022 | -36.58% |
| Jun 30, 2022 | 22.39% |
| Mar 31, 2022 | -39.91% |
| Dec 31, 2021 | 6.91% |
| Sep 30, 2021 | 45.59% |
| Jun 30, 2021 | -1.89% |
| Mar 31, 2021 | 3.93% |
| Dec 31, 2020 | -50.79% |
| Mar 31, 2018 | 700.00% |
| Dec 31, 2017 | -100.87% |
| Sep 30, 2017 | 1,816.67% |
| Jun 30, 2017 | -97.00% |
| Dec 31, 2013 | -70.64% |
| Sep 30, 2013 | -48.28% |
| Jun 30, 2013 | 29.47% |
| Mar 31, 2013 | -34.07% |
| Dec 31, 2012 | 9.30% |
| Sep 30, 2012 | 131.84% |
| Jun 30, 2012 | 140.76% |
| Mar 31, 2012 | 798.61% |
| Dec 31, 2011 | 62.95% |
| Sep 30, 2011 | 20.30% |
| Jun 30, 2011 | 203.02% |
| Mar 31, 2011 | 187.31% |
| Dec 31, 2010 | -102.11% |